CTSS and pulmonary emphysema: CTSS-deficient mice demonstrated protection against smoke-induced pathologies including pulmonary inflammation, airway hyperresponsiveness, emphysema, and lung function decline, while Protein Phosphatase 2A (PP2A) activation suppresses CTSS-driven pulmonary disorders (35).